Prostate cancer is the second-leading cancer killer of men after lung cancer. This year, an estimated 186,000 men in this country will be diagnosed with prostate cancer and about 28,000 will die from the disease.
A new study published in the Journal of Clinical Oncology found that the pill abiraterone shrank the size of tumors in men with advanced prostate cancer and doubled their rate of survival.
Many researchers in the medical community agree that the abiraterone, in phase III clinical trials, will produce promising results. Cougar Biotechnology Inc. of Los Angeles, the company which owns abiraterone, expects the drug to reach the market in 2011.
For more information on clinical trials of abiraterone, check out The National Institute of Health also allows you to customize a search to find clinical trials that treat prostate cancer, and are currently enrolling partients.
In the meantime, here are links to resources which can help you make sense of prostate cancer:
Cancer.Net, a cancer information site from the American Society of Clinical Oncology, outlines a complete guide to prostate cancer, from risk factors and prevention, to treatment and links, to new research.
Their "Newly Diagnosed: First Steps to Take Guide" provides comprehensive links to information on the diagnosis, finding care, and getting organized for treatment.
For complete information on current treatment options for prostate cancer, check out the "Report to the Nation on Prostate Cancer: A Guide for Men and Their Families" from the Prostate Cancer Foundation.
The Lance Armstrong Foundation offers links to resources on how to manage prostate cancer from diagnosis to treatment.